About: Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 30 November 2012

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2012 (fr) наукова стаття, опублікована в листопаді 2012 (uk) scientific article published on 30 November 2012 (en) artículu científicu espublizáu en payares de 2012 (ast)
publication date	wds:Q85574656-9A64A0DB-1A0A-491A-BE59-095751F50301
publication date	2012-11-30 00:00:00Z (xsd:dateTime)
exact match	wds:Q85574656-8B2C89F2-88B1-46CB-A188-50BC12E4EF0F
exact match	https://scigraph.springernature.com/pub.10.1038/modpathol.2012.206
cites work	wds:Q85574656-0C776654-6173-4B31-87C7-3997C81A7969 wds:Q85574656-1093D83F-A593-428C-883F-AA636F7DEC4C wds:Q85574656-379F0F9D-E576-492E-ADCD-357B4A90BE78 wds:Q85574656-38C376DE-BC4B-4BB4-88A6-72CF184DD9A4 wds:Q85574656-3F165F66-4228-4098-B1F5-C67C99D2022C wds:Q85574656-4800D01D-8F78-4EFE-BF68-EC4898CABD81 wds:Q85574656-4A0253EF-D991-4564-86C1-D396A5D98658 wds:Q85574656-4B07A73D-394E-4C5A-A39C-6B168316760E wds:Q85574656-5049551B-03D5-42A8-8CCA-FA1C9A24C4D7 wds:Q85574656-6317FF81-4564-4497-B107-F2F62591B3DE wds:Q85574656-641D4ADA-B7F5-465D-880E-73EB9B272EF3 wds:Q85574656-67E5E532-4FA6-437A-B2D5-A026C0A1B284 wds:Q85574656-827B8BBB-CBED-4570-B959-5A710DDBED6A wds:Q85574656-88445DE6-88B6-4F41-A60E-9F6C3EA4315B wds:Q85574656-924689DB-589A-4683-9D82-186D7C8177C0 wds:Q85574656-9AEC8245-1684-40D9-A693-4723F2A16386 wds:Q85574656-B3AB8F17-5B43-49F8-892E-C7396302597D wds:Q85574656-B45407A8-D522-47BA-841D-883ED95930B1 wds:Q85574656-B88135CF-60E7-481A-8CA0-1C1185E09B9E wds:Q85574656-B9AD73BC-887E-4A7E-8C2A-C2398BB8FDC1 wds:Q85574656-C8218B25-19DB-490C-8EA8-4AF41E08D41C wds:Q85574656-D49E57EB-1DEF-431C-9910-8322F2B468DD wds:Q85574656-D58C8DDB-6222-46B8-8B49-DDD143767C35 wds:Q85574656-DB8C884E-38C1-4B36-8F6E-136A4E2FA1B9 wds:Q85574656-DE7C45DD-4A1D-4EAB-B02C-47F2A17A7B58 wds:Q85574656-E20F1DB7-4CCE-4A69-9ABC-D334F8F3FA03 wds:Q85574656-E707C135-7A4E-45FF-9C15-54729465DF0C wds:Q85574656-F44CB2BB-2CB8-4366-A24F-3F23BFB88242 wds:Q85574656-FB26CFF7-3F73-482B-8A96-0D1FD6DD39B0 wds:Q85574656-FB736ECC-BA14-4907-9F5D-5927FC5524F1
cites work	Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy The human cysteine-rich secretory protein (CRISP) family. Primary structure and tissue distribution of CRISP-1, CRISP-2 and CRISP-3 Role of the TMPRSS2-ERG gene fusion in prostate cancer Tissue microarrays for high-throughput molecular profiling of tumor specimens Integrative genomic profiling of human prostate cancer Cancer statistics, 2010 FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue The CAP superfamily: cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins--roles in reproduction, cancer, and immune defense In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3. Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling. Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer Full functional-length urethral sphincter preservation during radical prostatectomy The genomic complexity of primary human prostate cancer ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patien Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome
author name string	wds:Q85574656-30FFF40B-49F0-4BC0-9DFE-71FBD46D0A23 wds:Q85574656-4BE16E14-CA72-4EA0-AD65-B0A7D4FD6325 wds:Q85574656-62FB79F1-7B61-43FD-AC24-F8A4D8DF137D wds:Q85574656-6D100B04-6A7C-48CF-8A26-294C743A19A6 wds:Q85574656-7A919A1E-E08A-4105-9C00-B346DEA46B6A wds:Q85574656-7DE8EB8B-4350-4CD3-B592-F5AEA29CE1F7 wds:Q85574656-7F7D473F-EA0B-4B4F-BD0E-F48B0A342AA9 wds:Q85574656-AB779031-8795-43C7-944F-CEC4193D1147 wds:Q85574656-B831646C-BDD2-4D81-B0B4-6CB007D1C06F wds:Q85574656-B8B4B6B8-0CB0-436A-BA7D-8F8C9B820D4D wds:Q85574656-E012FC7A-EB5C-4D15-9090-D49BBE3B5296
author name string	Jakob Izbicki Guido Sauter Andreas Becker Sarah Minner Thorsten Schlomm Maria Christina Tsourlakis Stefan Steurer Hüseyin Sirma Katharina Grupp Meike Adam Sebastian Kohl
rdfs:label	Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence (en) Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence (nl)
skos:prefLabel	Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence (en) Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence (nl)
name	Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence (en) Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence (nl)
author	wds:Q85574656-586F2C5E-ACE5-4A62-8552-B5C6EDE5F833
author	Ronald Simon

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 173 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software